AFYA Earnings

AFYA reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 928.50M against an estimate of 926.30M, resulting in a 0.24% surprise. The EPS was 0, surpassing the expected 0.31 by 0%. The stock experienced a 0.14% price change on the earnings day and a 0.35% change over the next five days, reflecting market reactions to the results.

Following AFYA's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by 0.14% on the day of the release. Over the subsequent five days, it saw a 0.35% change. Historically, AFYA's stock price tends to shift by an average of -2.02% in the 10 days leading up to earnings and 2.82% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate AFYA's annual revenue to reach 924.27M, while the EPS is projected at 1.94. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between AFYA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, AFYA's stock price typically moves by -2.02% in the 10 days before its earnings and 2.82% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.94 and revenue of 924.27M.

The earnings call summary indicates strong financial performance with significant revenue and EBITDA growth, increased medical seats, and a share repurchase program. The Q&A session reveals some uncertainties, such as the impact of new tax reforms and unclear guidance for 2026. However, the company's strategic capital allocation and expected tuition growth contribute positively. Given the market cap of approximately $1.5 billion, the positive sentiment is likely to result in a moderate stock price increase in the range of 2% to 8%.